Could Virtual Twin Technology Support Model-informed Precision Dosing?
Understand the role that Virtual Twin Technology can play in Model-Based Precision Dosing to lead to better patient outcomes.
Understand the role that Virtual Twin Technology can play in Model-Based Precision Dosing to lead to better patient outcomes.
PRINCETON, NJ – June 25, 2019 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr. Katrina Hui, Dr. Yu-Wei Lin, and Dr. Zheng Liu.